Table-I.
Baseline characteristics and parameter of study participants (n=181).
| Characteristics | n(%) | Characteristics | n(%) |
|---|---|---|---|
| Gender | Neuropathy | ||
| Male | 90(49.7) | Present | 32(17.7) |
| Female | 91(50.3) | Absent | 149(82.3) |
| Age Group | Oral Hypoglycemic Agents | ||
| 33 -45 years | 28(15.5) | Yes | 21(11.6) |
| 46 - 75 years | 133(73.5) | No | 160(88.4) |
| >75 years | 20(11.0) | Calcium Channel Antagonists | |
| Co-morbidity | Yes | 5(2.8) | |
| None | 151(83.4) | No | 176(97.2) |
| Hypertension | 20(11.0) | Beta Blockers | |
| Hypertension and ischemic heart disease | 10(5.5) | Yes | 3(1.7) |
| Retinopathy | No | 178(98.3) | |
| Present | 16(8.8) | Insulin | |
| Absent | 165(91.2) | Yes | 24(13.3) |
| No | 157(86.7) | ||
| Parameters | Mean ± SD | Parameters | Mean ± SD |
| Age (Years) | 59 ± 12.8 | FBS | 179.6 ± 77.6 |
| Duration of Diabetes (years) | 10.6 ± 7.3 | Sodium | 140.2 ± 6.1 |
| Weight | 71 ± 17.6 | Potassium | 4.2 ± 0.53 |
| Height | 162.5 ± 10 | Chloride | 101.9 ± 5.9 |
| BMI | 25.5 ± 5.6 | Magnesium | 1.9 ± 0.33 |
| Urine for microalbumin | 42.3 ± 63 | ||